Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)

About the company

Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline is OCALIVA which is used for the treatment of primary biliary cholangitis, nonalcoholic steatohepatitis, primary sclerosing cholangitis, and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in New York, NY.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

583

$283.00M

Total Revenue

583

Employees

$1B

Market Capitalization

-3.89

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$277M

Operating Margin (in %)

Total operating margin

$-300M

Net Margin (in %)

Total net margin

$-339M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 16714.08 1518.00 7.35 30.09 34.09
Catalent, Inc. CTLT 13003.60 3094.00 4.86 75.04 5.59
Jazz Pharmaceuticals Plc JAZZ 7921.86 2217.00 2.45 60.16 6.01
Perrigo Co. Plc PRGO 6291.04 5074.00 1.06 26.24 4.73
MyoKardia, Inc. MYOK 5938.45 34.00 7.37 -17.57 -201.73
Bausch Health Cos., Inc. BHC 5831.56 8109.00 12.33 -2.85 -25.19
United Therapeutics Corp. UTHR 4444.44 1431.00 1.45 10.36 30.04
SAGE Therapeutics, Inc. SAGE 3107.00 9.00 4.20 -5.06 -413.06
Axsome Therapeutics, Inc. AXSM 2789.46 None 18.76 -29.24 None
Pacira Biosciences, Inc. PCRX 2510.34 408.00 6.58 -239.08 -2.47
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
Corcept Therapeutics, Inc. CORT 2212.77 351.00 4.58 19.14 32.49
Revolution Medicines, Inc. RVMD 1951.13 46.00 6.05 -22.97 -183.83
Madrigal Pharmaceuticals, Inc. MDGL 1855.65 0.00 5.57 -14.20 -624.74
Prestige Consumer Healthcare, Inc. PBH 1809.22 960.00 1.45 11.86 15.84
Ironwood Pharmaceuticals, Inc. IRWD 1532.60 427.00 -42.17 15.65 22.74
Revance Therapeutics, Inc. RVNC 1420.02 0.00 7.47 -6.85 41.82
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Intercept Pharmaceuticals, Inc. ICPT 1326.93 283.00 -16.82 -3.89 -119.73
Innoviva, Inc. INVA 1272.38 299.00 2.50 5.49 76.18
Supernus Pharmaceuticals, Inc. SUPN 1161.00 424.00 1.70 9.77 27.85
Zogenix, Inc. ZGNX 1095.36 5.00 3.12 -2.39 -241.62
Theravance Biopharma, Inc. TBPH 1003.59 77.00 -5.33 -3.70 -351.55
Amphastar Pharmaceuticals, Inc. AMPH 920.71 334.00 2.24 234.88 1.21
BellRing Brands, Inc. BRBR 728.52 920.00 -0.34 5.38 14.84
Endo International Plc ENDP 722.20 3002.00 -1.01 -4.36 -5.25
Collegium Pharmaceutical, Inc. COLL 633.42 302.00 4.13 -1863.00 0.07
Eagle Pharmaceuticals, Inc. EGRX 556.36 177.00 2.94 -120.42 -2.54
Assembly Biosciences, Inc. ASMB 536.61 52.00 2.13 -6.92 -136.24
Aerie Pharmaceuticals, Inc. AERI 532.22 82.00 5.99 -2.62 -247.36
Intersect ENT, Inc. XENT 530.24 85.00 6.09 -8.68 -71.96
Albireo Pharma, Inc. ALBO 526.68 11.00 8.02 -6.39 -722.91
Anika Therapeutics, Inc. ANIK 481.18 126.00 1.69 44.06 9.03
Qualigen Therapeutics, Inc. QLGN 449.00 17634.00 0.12 -14.48 -0.18
BioDelivery Sciences International, Inc. BDSI 383.18 137.00 4.65 55.86 4.23
Catalyst Pharmaceuticals, Inc. CPRX 343.47 120.00 3.00 8.23 34.87
ANI Pharmaceuticals, Inc. ANIP 338.76 198.00 1.82 -16.61 -10.21
MEI Pharma, Inc. MEIP 296.66 29.00 4.66 -6.39 -159.15
Marinus Pharmaceuticals, Inc. MRNS 240.75 0.00 4.22 -3.28 None
Agile Therapeutics, Inc. AGRX 238.70 None 3.67 -8.32 None
Cassava Sciences, Inc. SAVA 206.22 41.00 10.12 -44.64 76.71
Ampio Pharmaceuticals, Inc. AMPE 167.40 1.00 27.00 -7.71 None
AcelRx Pharmaceuticals, Inc. ACRX 144.80 4.00 -2.70 -2.92 -644.25
Adamas Pharmaceuticals, Inc. ADMS 133.84 64.00 -5.56 -1.71 -122.52
Cerecor, Inc. CERC 129.03 7.00 3.83 -4.52 -530.21
Evoke Pharma, Inc. EVOK 112.56 397.00 -469.00 -9.98 -0.76
Mallinckrodt Plc MNK 106.68 2381.00 0.11 -0.05 -89.95
Aclaris Therapeutics, Inc. ACRS 90.20 4.00 1.58 -0.65 None
Aclaris Therapeutics, Inc. ACRS 86.92 4.00 1.53 -0.63 None
Zynerba Pharmaceuticals, Inc. ZYNE 84.00 0.00 1.38 -1.90 -699.94
CTI BioPharma Corp. CTIC 69.93 2.00 1.44 -1.61 -111.83
Lipocine, Inc. LPCN 56.61 0.00 7.65 -3.12 None
Oramed Pharmaceuticals, Inc. ORMP 52.63 3.00 1.91 -4.86 -398.34
Cumberland Pharmaceuticals, Inc. CPIX 49.95 47.00 1.04 -10.41 -10.33
Natural Alternatives International, Inc. NAII 47.18 119.00 0.62 -26.96 -1.38
SCYNEXIS, Inc. SCYX 40.00 0.00 8.33 -1.03 -30.84
IsoRay, Inc. ISR 39.53 9.00 7.37 -11.80 -36.08
Neos Therapeutics, Inc. NEOS 32.40 62.00 -1.96 -1.71 -30.64
PLx Pharma, Inc. PLXP 28.04 0.00 -1.75 -5.46 119.04
Acasti Pharma, Inc. ACST 24.64 0.00 2.55 -1.17 -611.47
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
Tonix Pharmaceuticals Holding Corp. TNXP 21.39 None 2.27 0.49 None
Intec Pharma Ltd. NTEC 18.98 None 1.38 -0.30 None
Sonoma Pharmaceuticals, Inc. SNOA 18.02 22.00 1.60 -4.53 -12.24
Hepion Pharmaceuticals, Inc. HEPA 16.25 None 1.77 0.42 None
EyeGate Pharmaceuticals, Inc. EYEG 14.72 3.00 2.18 -1.36 -264.21
Regulus Therapeutics, Inc. RGLS 13.20 0.00 2.29 -0.58 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 11.00 8.00 0.59 -0.13 -798.18
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
VIVUS, Inc. VVUS 4.21 73.00 -0.09 -0.14 -39.28
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Could Intercept Pharmaceuticals Be a Millionaire-Maker Stock?

9d ago, source: Nasdaq

If Intercept gets approval to treat NASH patients with Ocaliva, that would be a huge deal -- 12% of the U.S. population, or almost 40 million people, have the disease, according to the NASH Education ...

Intercept Pharmaceuticals Inc.

11d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Intercept's (ICPT) Stock Rises After Layoff Announcement

7d ago, source: YAHOO!

Shares of Intercept Pharmaceuticals, Inc. ICPT were up 3.5% on Wednesday, after it announced that it will lay off 25% of its workforce, or about 170 employees. The company made the announcement two ...

Alcoholic Hepatitis Therapeutic Market Overview, New Opportunities & SWOT Analysis by 2025

12d ago, source: MarketWatch

Some of the important players from a wide list of coverage used under bottom-up approach are Alkermes Inc. (Ireland ... Lupin Laboratories (India),Intercept Pharmaceuticals (United States ...

Could Intercept Pharmaceuticals Be a Millionaire-Maker Stock?

9d ago, source: Nasdaq

Intercept Pharmaceuticals (NASDAQ: ICPT) is like a lot of biopharmaceutical stocks: It's not making money, but all it takes is one major drug to turn things around. Intercept, founded in 2002 and ...

Intercept Pharmaceuticals Inc.

11d ago, source: MarketWatch

11/08/2018 128 Derivative/Non-derivative trans. at $113.79 per share. 14,566 08/08/2018 128 Derivative/Non-derivative trans. at $116.84 per share. 14,956 ...

Intercept Pharmaceuticals Inc ICPT

11d ago, source: Morningstar%2c Inc.

Intercept reported second-quarter results that outperformed our estimates on both revenue and operating expenses. However, the financial results are overshadowed by the disappointing news ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.